Greenleaf Trust Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Greenleaf Trust grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,619 shares of the company’s stock after buying an additional 124 shares during the quarter. Greenleaf Trust’s holdings in GE HealthCare Technologies were worth $715,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares during the last quarter. Bank of Montreal Can lifted its stake in GE HealthCare Technologies by 27.5% in the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock valued at $54,964,000 after buying an additional 150,137 shares in the last quarter. Sei Investments Co. grew its holdings in GE HealthCare Technologies by 30.6% during the 1st quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock valued at $25,393,000 after buying an additional 65,476 shares during the last quarter. Chevy Chase Trust Holdings LLC increased its position in GE HealthCare Technologies by 7.1% during the first quarter. Chevy Chase Trust Holdings LLC now owns 235,436 shares of the company’s stock worth $21,403,000 after buying an additional 15,522 shares in the last quarter. Finally, BNP Paribas purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at $30,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 0.5 %

Shares of NASDAQ GEHC opened at $88.42 on Friday. The stock’s 50 day moving average price is $88.42 and its two-hundred day moving average price is $83.45. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.55. The stock has a market capitalization of $40.36 billion, a P/E ratio of 25.85, a PEG ratio of 3.39 and a beta of 1.18. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same period last year, the firm posted $0.92 EPS. The company’s revenue for the quarter was up .5% on a year-over-year basis. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Analyst Ratings Changes

A number of research firms recently commented on GEHC. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $94.23.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.